Chemotherapy in epithelial ovarian cancer
| Autor: | Gaetano Facchini, Sandro Pignata, Lucia Cannella, Carmela Pisano, Davide Leopardo, Giovanni Salvatore Bruni |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Oncology
Cancer Research medicine.medical_specialty Poor prognosis endocrine system diseases medicine.medical_treatment Antineoplastic Agents Medical Oncology Drug Therapy Recurrence Internal medicine medicine Humans Epithelial ovarian cancer Ovarian tissue cryopreservation Stage (cooking) Aged Ovarian Neoplasms Clinical Trials as Topic Chemotherapy business.industry Cancer Middle Aged Prognosis medicine.disease Treatment Outcome Female Ovarian cancer business Adjuvant |
| Zdroj: | Cancer Letters. 303:73-83 |
| ISSN: | 0304-3835 |
| DOI: | 10.1016/j.canlet.2011.01.026 |
| Popis: | Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50 years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect